This infographic explores a contemporary strategy to decrease the risk of cardiovascular disease and mortality associated with end-stage kidney disease (ESKD). In haemodialysis patients, these outcomes are often linked to the interaction between malnutrition and inflammation. Improving cardiovascular outcomes for patients with ESKD requires an understanding of the mechanisms of inflammation and malnutrition and the role of pro-inflammatory uraemic toxins.
Latest articles
All articles
4 Mins
14th
February
Lupus Vasculitis, A Rare Diagnosis and a Therapeutic Challenge
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may manifest with…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
7 Mins
23rd
August
Proliferative Lupus Nephritis with Focal Extracapillary Proliferation in Latin America
This study investigates the impact of extracapillary proliferation in proliferative lupus nephritis on remission rates in patients.
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
6 Mins
24th
July
Interview: David Wheeler
When I was a junior doctor, I was exposed to a number of different chronic diseases. However, kidney disease fascinated me the most…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.